Table 1 The clinical characteristics between Low-risk and High-risk group.
Characteristics | Low Risk | High Risk | P-value | Statistic | Method |
|---|---|---|---|---|---|
n | 275 | 274 | |||
Age, n (%) | 0.244 | 1.359 | Chisq test | ||
< 65 | 128 (23.3%) | 114 (20.8%) | |||
> 65 | 147 (26.8%) | 160 (29.1%) | |||
Gender, n (%) | 0.370 | 0.803 | Chisq test | ||
Female | 120 (21.9%) | 130 (23.7%) | |||
Male | 155 (28.2%) | 144 (26.2%) | |||
Stage, n (%) | < 0.001 | 30.159 | Chisq test | ||
I | 70 (12.8%) | 29 (5.3%) | |||
II | 105 (19.1%) | 100 (18.2%) | |||
III | 75 (13.7%) | 89 (16.2%) | |||
IV | 25 (4.6%) | 56 (10.2%) | |||
M, n (%) | < 0.001 | 14.050 | Chisq test | ||
M0 | 250 (45.5%) | 218 (39.7%) | |||
M1 | 25 (4.6%) | 56 (10.2%) | |||
Pathologic_N, n (%) | < 0.001 | 23.038 | Chisq test | ||
NO | 177 (32.2%) | 136 (24.8%) | |||
N1 | 69 (12.6%) | 67 (12.2%) | |||
N2 | 29 (5.3%) | 71 (12.9%) | |||
Pathologic_T, n (%) | < 0.001 | 34.016 | Chisq test | ||
T1 | 13 (2.4%) | 5 (0.9%) | |||
T2 | 65 (11.8%) | 32 (5.8%) | |||
T3 | 185 (33.7%) | 192 (35%) | |||
T4 | 12 (2.2%) | 45 (8.2%) | |||
Status, n (%) | < 0.001 | 40.676 | Chisq test | ||
Alive | 251 (45.7%) | 191 (34.8%) | |||
Dead | 24 (4.4%) | 83 (15.1%) | |||
MSI_status, n (%) | 0.983 | 0.035 | Chisq test | ||
MSS | 183 (35.8%) | 176 (34.4%) | |||
MSI-L | 41 (8%) | 41 (8%) | |||
MSI-H | 36 (7%) | 34 (6.7%) | |||
